Trametinib shows promise for children with relapsed or refractory JMML
Bottom Line: The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Bottom Line: The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic...
WASHINGTON – A new detailed analysis of a patient’s second cancer after receiving CAR-T therapy for the initial cancer provides...
Jacksonville, Fla. – Three University of North Florida (UNF) researchers have been awarded a U.S. patent for a targeted cancer-fighting...
Louisiana’s southeastern corridor is sometimes known colloquially as “Cancer Alley” for its high cancer incidence rates connected to industrial air...
Engineers at the University of California San Diego have developed microscopic robots, known as microrobots, capable of swimming through the...
AI detects prostate cancer more often than radiologists. Additionally, AI triggers false alarms half as often. This is shown by...
Sarcopenia is associated with the prognosis of patients with liver cirrhosis and hepatocellular carcinoma (HCC). Given their diverse physiological activities,...
Immune system cells called macrophages play an unexpected role in the complicated connection between obesity and cancer, a Vanderbilt University...
About The Study: Neighborhood deprivation was associated with increased breast cancer mortality among non-Hispanic white women in this cohort study. Neighborhood...
T-cell stimulating biomaterial that slowly biodegrades under the skin stimulates CAR-T cells in the body to improve therapeutic efficacy in...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine